Summary
Fasting initiates a multitude of adaptations to allow survival. Activation of the hypothalamic-pituitary-adrenal (HPA) axis and subsequent release of glucocorticoid hormones is a key response that mobilizes fuel stores to meet energy demands1-5. Despite the importance of the HPA axis response, the neural mechanisms that drive its activation during energy deficit are unknown. Here, we show that fasting-activated hypothalamic agouti-related peptide (AgRP)-expressing neurons trigger and are essential for fasting-induced HPA axis activation. AgRP neurons do so via projections to the paraventricular hypothalamus (PVH), where, in a mechanism not previously described for AgRP neurons, they presynaptically inhibit the terminals of tonically active GABAergic afferents from the bed nucleus of the stria terminalis (BNST) that otherwise restrain activity of corticotrophin-releasing hormone (CRH)-expressing neurons. This disinhibition of PVHCrh neurons requires GABA (γ-aminobutyric acid)/GABA-B receptor signaling and potently activates the HPA axis. Importantly, stimulation of the HPA axis by AgRP neurons is independent of their induction of hunger, showing that these canonical ‘hunger neurons’ drive multiple adaptations to the fasted state. Together our findings identify the neural basis for fasting-induced HPA axis activation and uncover a unique means by which AgRP neurons activate downstream neurons – via presynaptic inhibition of GABAergic afferents. Given the potency of this disinhibition of tonically-active BNST afferents, other activators of the HPA axis, such as psychological stress, may also work by reducing BNST inhibitory tone onto PVHCrh neurons.
Introduction
Fasting triggers behavioral, physiologic and metabolic responses which collectively are vital for survival. One of these is activation of the HPA axis (Extended Data Fig. 1a)1-5 which increases blood levels of adrenal glucocorticoid (GC) hormones – cortisol in humans5 and corticosterone in rodents1-4. This adaptive response serves to prevent fasting-induced drops in blood glucose3,4,6. Absence of this response during fasting, in humans with reduced adrenal function6,7 or when GC function is blocked in rodents3 impairs key metabolic responses, leading to hypoglycemia. Glucocorticoid hormones maintain glucose homeostasis by a series of interconnected, combined effects; by directly stimulating glucose-synthesizing gluconeogenic pathways in the liver8,9, by mobilizing gluconeogenic precursors from muscle protein10, and by stimulating lipolysis in adipocytes3,11- the latter of which generates glycerol, yet another gluconeogenic precursor, and free fatty acids that are then used as alternative fuel by peripheral tissues, sparing the limited glucose supply for the brain.
Despite the importance of fasting-activation of the HPA axis, the mechanism that causes this is unknown. That said, it appears to be triggered by a fall in the adipose tissue-derived hormone leptin1-3. Given that AgRP-expressing neurons within the arcuate nucleus of the hypothalamus (ARC) are activated by fasting, in part by leptin deficiency, and that numerous other adaptive responses triggered by fasting are also caused by increased AgRP neuron activity12-14, we hypothesized that AgRP neurons are responsible for fasting-activation of the HPA axis. A recent publication attempted to address this hypothesis but obtained conflicting results15 and therefore, whether AgRP neurons regulate the HPA axis is unknown, as is the mechanism by which they might bring about such regulation.
Results
AgRP neurons activate the HPA axis
The HPA axis is strongly activated by fasting and is inversely related to levels of leptin1,3. We confirmed that plasma corticosterone, which is strongly elevated in 24-hour fasted mice, is suppressed by leptin (Extended Data Fig. 1b-d). Since AgRP neuron activity is increased by fasting and low leptin, we asked whether it is indeed the increased AgRP neuron activity that is actually responsible for increasing plasma corticosterone. To activate AgRP neurons, we expressed hM3Dq bilaterally in the ARC of Agrp-IRES-Cre mice (Fig. 1a, Extended Data Fig. 3a, b). Trunk blood was collected 1 hour after clozapine-N-oxide (CNO) injection during the early light cycle when endogenous corticosterone is low (Fig. 1b). Activation of AgRP neurons in ad libitum fed animals substantially increased plasma corticosterone (Fig. 1c). Conversely, inhibition of AgRP neurons using hM4Di completely suppressed fasting-levels of corticosterone (Fig. 1a, d, e, Extended Data Fig. 3c, d). Together these data demonstrate that leptin-sensitive AgRP neurons drive corticosterone release and are vitally important for this response during fasting.
Release of GCs occurs by step-wise activation of the HPA axis, with the first step in the pathway being excitation of PVHCrh neurons16 (Extended Data Fig. 1a). To assess whether AgRP neurons activate the HPA axis we recorded intracellular calcium levels from PVHCrh neurons as a proxy for neuronal activity, via fiber photometry, while simultaneously activating AgRP neurons using CNO/hM3Dq (Fig. 1f, g, Extended Data Fig. 3e). The I.P. injection itself caused a brief stress response but, only CNO injection in mice expressing hM3Dq in AgRP neurons drove rapid and sustained activation of PVHCrh neurons (Fig. 1h, i), which was not observed in mice expressing mCherry in AgRP neurons (Fig. 1j, k). Importantly, inhibition of AgRP neurons in fasted animals reduced PVHCrh neuron activity (Fig. 1f, l, m). This effect is likely partial given incomplete transduction of AgRP neurons with hM4Di (Extended Data Fig. 3f, g) due to the small volumes of AAV necessary to avoid DREADD expression in PVHCrh neurons in Agrp-IRES-Cre::Crh-IRES-Cre mice. Finally, consistent with engagement of the HPA axis, brief optogenetic stimulation of AgRP neurons strongly increased plasma adrenocorticotropic hormone (ACTH) as well as corticosterone (Fig. 1n, q; Extended Data Fig. 1e, f, Extended Data Fig. 3h, i). Thus, AgRP neurons drive corticosterone release via the HPA axis.
HPA axis activation is independent of hunger
Given that PVHCrh neurons are the apex of the HPA axis, we hypothesized that PVH-projecting AgRP neurons cause activation of the HPA axis. To test this, we optogenetically stimulated discrete projection fields of AgRP neurons in vivo using bilateral expression of Channelrhodopsin-2 (ChR2) (Fig. 2a, b, Extended Data Fig. 4a-d, Extended Data Fig. 5a-d). Stimulation of AgRP terminals in the PVH, and also surprisingly in the BNST and lateral hypothalamus (LH), all caused similar increases in plasma corticosterone (Fig. 2c). In contrast, stimulation of terminals in the parabrachial nucleus (PBN) had no effect (Fig. 2c). Coincidentally, the same AgRP neuron projections that activate the HPA axis, i.e., to the BNST, LH and PVH, also have been shown to cause hunger17. This raises the possibility that it is stimulation of hunger itself, a motivational drive state that is aversive18, that actually causes HPA axis activation. To address this possibility, we looked one synapse downstream in the pathway by which AgRP neurons cause hunger – at the PVH melanocortin 4 receptor (MC4R)-expressing satiety neurons. These neurons, when inhibited by AgRP neurons, cause hunger19. Importantly, direct bilateral CNO/hM4Di-mediated inhibition of PVHMc4r neurons increased food intake (Extended Data Fig. 1g, h, Extended Data Fig. 10b, c) but did not affect plasma corticosterone (Extended Data Fig. 1i, j). Thus, hunger itself does not activate the HPA axis. Instead, HPA axis activation must be a distinct action of AgRP neurons that is independent of their ability to inhibit downstream PVH (MC4R-expressing) satiety neurons.
The PVH is the site of AgRP neuron action
AgRP neurons are proposed to be largely wired in a one-to-one manner, with different subsets of AgRP neurons projecting to different downstream sites17. If this is the case, then our ChR2 terminal stimulation of AgRP neurons (Fig. 2c) suggests that there exists in each of these downstream sites, the PVH, BNST and LH, neurons that when inhibited by AgRP neuron projections, activate the HPA axis. At first glance, this might be unexpected as the apex of the HPA axis, CRH neurons, lie in just one of these downstream sites, the PVH. If, on the other hand, there is a sufficient degree of collateralization in projections to the BNST, LH and PVH, then it is possible that optogenetic stimulation of axons in either the BNST or the LH antidromically activate collaterals that project to the PVH. Given the importance of this issue with regards to interpreting our ChR2 terminal stimulation studies, we used two approaches to assess collateralization of AgRP neuron projections. In the first, we injected a retrograde AAV-FlpO into distinct projection fields of AgRP neurons in Cre- and Flp-dependent GFP reporter mice (Agrp-IRES-Cre::FLTG) (Fig. 2d). The resulting GFP expression marks the projections, including all collaterals of AgRP neurons that project to the site of AAV-FlpO injection. This revealed that BNST- and LH-projecting AgRP neurons do indeed send some collaterals to the PVH (Fig. 2e, Extended Data Fig. 2a, b). PBN-projecting AgRP neurons, on the other hand, collateralize only in the periaqueductal gray (PAG) (Extended Data Fig. 2a, b). Recall that stimulation of AgRP terminals in the PBN failed to activate the HPA axis. Our second approach for looking at collaterals, rabies-based collateral mapping, yielded similar results (Extended Data Fig. 2c, d). Hence, in agreement with the prior study17, AgRP neurons are largely wired in a one-to-one fashion but there is some degree of collateralization in AgRP neurons that project to the LH, BNST and PVH. Given the existence of these collaterals, our ChR2 terminal stimulation studies are unable to establish whether neurons in the PVH, LH and/or BNST mediate AgRP neuron activation of the HPA axis. To examine this issue in a way not confounded by the existence of collaterals, we used a terminal-based inhibition approach. Specifically, we selectively inhibited synaptic transmission by AgRP neuron terminals using a light-activated Gi/o-coupled inhibitory opsin, eOPN320, and looked at effects on fasting activation of the HPA axis (Fig. 2f, g, Extended Data Fig. 6a-f). Importantly, bilateral terminal specific inhibition of AgRP projections in the PVH, but not in the LH or BNST, significantly reduced fasting levels of corticosterone (Fig. 2h). These data strongly suggest that AgRP neurons activate the HPA axis via their projections to the PVH.
AgRP neurons disinhibit PVHCrh neurons
We next investigated how AgRP neurons drive activity of PVHCrh neurons. This is a particularly compelling question because AgRP neurons release only inhibitory neurotransmitters (GABA, neuropeptide Y (NPY) and AgRP) and therefore are unlikely to activate the HPA axis via direct excitation of PVHCrh neurons. Consistent with this, as assessed using ChR2-assisted circuit mapping, AgRP neurons do not make monosynaptic connections with PVHCrh neurons, while they do make monosynaptic connections with PVHMc4r neurons which they inhibit to produce hunger19. Alternatively, AgRP neurons could activate PVHCrh neurons by inhibiting an intermediate, tonically active GABAergic afferent. Given that the PVH is the key site of AgRP neuron regulation of the HPA axis (Fig. 2h) and that all PVH neurons are glutamatergic21, we hypothesized that AgRP neurons inhibit GABAergic tone onto PVHCrh neurons by inhibiting the terminals of such GABAergic afferents. Of interest, prior studies have shown that NPY can reduce inhibitory tone onto unidentified PVH neurons22,23 and in other parts of the brain24. Similarly, GABA acting on presynaptic GABA-B-Rs reduces electrically-evoked GABA release onto PVHCrh neurons25. To re-examine this, we recorded electrically-evoked inhibitory post-synaptic currents (eIPSCs) onto PVHCrh neurons ex vivo using Crh-IRES-Cre::tdTomato mice to identify the CRH neurons (Fig. 3a). eIPSCs were assessed before and after bath application of NPY or the GABA-B receptor (GABA-B-R) agonist baclofen. We excluded a role for PVH melanocortin receptors, and hence released AgRP, because hM3Dq-mediated activation of ARC proopiomelanocortin (POMC) neurons, which release the MC3/4R agonist α-MSH, did not reduce corticosterone in the fasted state (Extended Data Fig. 1k-m, Extended Data Fig. 10d, e). This indicates that AgRP signaling at PVH melanocortin receptors is unlikely to be involved in driving the HPA axis. Consistent with the prior studies, bath application of NPY or baclofen, markedly reduced the amplitude of eIPSCs (Fig. 3b-d, g, h). Both effects were entirely blocked by application of an NPY2R or GABA-B-R antagonist (Fig. 3e, f, i). Further, NPY and baclofen both increased paired-pulse ratio while input resistance was unchanged, further demonstrating that both modulate presynaptic release (Fig. 3j-m). Thus, NPY and GABA can mediate presynaptic inhibition via their receptors located on GABAergic afferents to PVHCrh neurons. We then probed the relative importance of GABA-B-Rs and NPY2Rs by testing whether baclofen and NPY have additive effects on eIPSC amplitude. Baclofen application further suppressed eIPSC amplitude after NPY treatment, while NPY did not have an additive effect when applied after baclofen (Fig. 3n-p). These data suggest that GABA-B-Rs are likely expressed more densely and/or on a greater number of PVHCrh neuron afferent terminals compared to NPY2Rs, and that GABA-B-Rs may play a more prominent role in the disinhibition of PVHCrh neurons by AgRP neurons.
Next, we tested if NPY and GABA are required for AgRP neurons to activate the HPA axis. We optogenetically stimulated AgRP neurons in the absence of NPY (Agrp-IRES-Cre::NPY-KO mice) or in mice in which the vesicular GABA transporter, Slc32a1 (vGAT), was selectively removed from AgRP neurons (Agrp-IRES-Cre::vGATlox/lox mice) to prevent AgRP neuron-mediated GABA release (Fig. 4a, b, Extended Data Fig. 7a-d). The corticosterone response upon AgRP neuron stimulation was still intact in the absence NPY or vGAT but was entirely lost in the double knockout animals (Fig. 4c). Intriguingly, the corticosterone response to stimulation of AgRP neurons was blunted in Agrp-IRES-Cre::vGATlox/lox mice compared to Agrp-IRES-Cre::NPY-KO mice. This, along with our ex vivo pharmacology data (Fig. 3n-p), demonstrates that GABA release from AgRP neurons acting on GABA-B-Rs may play a greater role in activation of the HPA axis than NPY. To explore this idea further, we next asked whether NPY and/or GABA signaling in the PVH specifically is required for the fasting increase in HPA axis activity. We infused NPY2R (BIIE0246) and/or GABA-B-R (Saclofen) antagonists into the PVH of fasted mice (Fig. 4d, e, Extended Data Fig. 8a-d). Although vehicle infusion itself caused high corticosterone levels in fed mice presumably due to the stress of infusion, blockade of NPY2Rs had no effect on the further elevation of corticosterone caused by fasting, while the GABA-B-R antagonist alone and in combination with the NPY2R antagonist strongly reduced fasting levels of plasma corticosterone (Fig. 4f). All together these data support a model where GABA release from AgRP neurons acting on GABA-B-R-expressing afferents in the PVH is required to activate the HPA axis. However, given that NPY can compensate to some degree when GABA is chronically absent in Agrp-IRES-Cre::vGATlox/lox animals26 and is sufficient to activate the HPA axis when injected into the PVH27, we cannot eliminate a role for NPY/NPY2Rs. Furthermore, the potential redundancy between GABA and NPY demonstrates the importance of preserving this vital adaptation to the fasted state.
BNST (GABA) axon terminals are inhibited
We next sought to identify the source of GABAergic input to PVHCrh neurons that is inhibited by AgRP neurons. It is widely understood that the HPA axis is controlled by GABAergic afferent neurons that are tonically active and thus constrain the excitability of PVHCrh neurons28-31. We therefore identified the putative sites of GABAergic input specifically to PVHCrh neurons by performing EnvA pseudotyped monosynaptic rabies mapping (Extended Data Fig. 2e). Our rabies mapping revealed many putative afferents to PVHCrh neurons and several of these rabies-labelled brain regions are known to contain GABAergic neurons (Extended Data Fig. 2f-j.). Of these areas, the BNST is regarded as a key modulator of HPA axis activity, with the anteroventral BNST in particular having been shown to act as an inhibitory brake on the HPA axis32,33. ChR2-assisted circuit mapping verified that BNSTvGAT neurons potently inhibit PVH neurons, directly inhibiting both PVHCrh neurons and PVHnon-Crh neurons (Fig. 5a, b). Therefore, we hypothesized that AgRP neurons excite PVHCrh neurons by inhibiting BNST axon terminals in the PVH. If so, inhibition of BNSTvGAT neurons should stimulate the HPA axis. Indeed, chemogenetic inhibition of BNSTvGAT neurons in vGAT-IRES-Cre mice strongly increased plasma corticosterone to levels seen in fasted animals (Fig. 5c-e, Extended Data Fig. 9a, b). Similar inhibition of LH GABAergic neurons, however, was without effect (Fig. 5c-e, Extended Data Fig. 9c, d). We next performed terminal-specific inhibition of BNSTvGATPVH projections using eOpn3 (Fig. 5f-h, Extended Data Fig. 9e). eOpn3 prevents presynaptic neurotransmission via the Gi/o pathway in the same manner as GABA and NPY acting on GABA-B-Rs20 and NPY2Rs34, respectively, thus perfectly mimicking the effect of these transmitters released from AgRP neurons on BNSTvGATPVH neuron terminals. Terminal inhibition of BNSTvGATPVH neurons robustly stimulated plasma corticosterone (Fig. 5i). Thus, inhibition of BNSTvGAT PVH terminals disinhibits PVHCrh neurons and strongly activates the HPA axis.
Finally, we asked if AgRP neurons do indeed inhibit BNST axon terminals in the PVH. We performed fiber photometry recordings from BNST neuron terminals in the PVH using a GCaMP targeted to synaptic terminals (synaptophysin-targeted GCaMP6f) while optogenetically stimulating AgRP neuron terminals through the same fiber using ChrimsonR (Fig. 5j, k, Extended Data Fig. 10a). Stimulation of AgRP neurons with red light, rapidly and dramatically suppressed BNSTPVH synaptic GCaMP signal which recovered after cessation of the stimulation (Fig. 5l-n). Furthermore, AgRP neuron terminal varicosities are abundant and clearly in close proximity to BNST axon terminals and PVHCrh neuron somas within the PVH (Fig. 5o). Thus, AgRP neurons presynaptically inhibit BNST neuron terminals in the PVH. Together these data support a model where tonically active inhibitory afferents from the BNST strongly suppress PVHCrh neuron activity under non-fasting conditions. During fasting, elevated AgRP neuron activity and subsequent release of GABA into the PVH causes presynaptic inhibition of these BNST afferents. Ultimately, this reduces GABAergic tone onto PVHCrh neurons, potently stimulating the HPA axis (Fig. 5p).
Discussion
Activation of the HPA axis is an essential adaptive response to energy deficit. In response to a fast, the ensuing increase in blood glucocorticoids is important to maintain glucose homeostasis and supply metabolic substrates for use as fuel sources. Though clearance of glucocorticoids may be slowed during fasting35, the basis for fasting activation of the HPA axis had been unknown. Here, we provide a neural mechanism for fasting-induced glucocorticoid release by establishing that AgRP neurons drive the HPA axis. Through a mechanism novel for AgRP neurons, they do so by releasing GABA into the PVH to engage GABA-B-Rs on GABAergic afferents to PVHCrh neurons, reducing GABAergic input onto PVHCrh neurons. Furthermore, we identified the presynaptic terminals of BNSTvGAT neurons as a specific target of AgRP neurons, which causes disinhibition of PVHCrh neurons, driving their activity and a surge in corticosterone. Importantly, we also show that AgRP neuron control of the HPA axis occurs in parallel to and via a downstream neural pathway distinct from AgRP neuron-driven hunger and feeding. Together these data reveal important mechanisms underlying AgRP neuron function in driving critical adaptive responses to energy deficit.
Disinhibition drives the HPA axis
The activity of PVHCrh neurons and the HPA axis is thought to be constrained by tonically active GABAergic afferents28-31. It therefore follows that activation of the HPA axis requires removal of tonic inhibition to allow excitation of PVHCrh neurons. Here, we provide strong evidence that disinhibition of GABAergic afferents to PVHCrh neurons potently causes HPA axis activation. PVHCrh neurons are excited by AgRP neuron-mediated release of GABA and NPY, which activate GABA-B-Rs and NPYRs on presynaptic terminals of GABAergic BNST neurons in the PVH. This presynaptic inhibition of GABA release, or disinhibition, reduces GABAergic tone onto PVHCrh neurons and causes their activation. A role for such presynaptic disinhibition is supported by a number of observations. First, NPY and GABA reduce inhibitory tone onto PVHCrh neurons in ex vivo brain slices (Fig. 3 and 22,23,25). Second, in vivo eOpn3 inhibition of BNST terminals in the PVH potently increases glucocorticoids. Of note, eOpn3 inhibits presynaptic transmission by blocking calcium channel activity20 through a Gi/o pathway, thus, closely mimicking the effects of GABA/GABA-B-Rs and NPY/NPYRs on BNST terminals. And third, activation of AgRP neurons potently inhibits BNSTPVH neuron terminals. Together, these data show that GABA and NPY released from AgRP neurons act on GABA-B-Rs and NPYRs on BNSTPVH neuron terminals to reduce their activity, thus preventing release of GABA and relieving inhibition of PVHCrh neurons.
Although we have established that GABA and NPY are individually sufficient to reduce GABAergic transmission onto PVHCrh neurons ex vivo, in vivo we found infusion of a GABA-B-R antagonist into the PVH was alone sufficient to profoundly reduce corticosterone levels during fasting. Furthermore, AgRP neuron-mediated corticosterone release was reduced in mice lacking vGAT (hence GABA release) compared to mice that lack NPY, which is consistent with more potent suppression of GABAergic tone onto PVHCrh neurons by GABA/GABA-B-Rs. Together these data support a more prominent role for GABA in AgRP neuron-driven activation of the HPA axis. Nevertheless, AgRP neuron-mediated corticosterone release was totally abolished only in the absence of both vGAT and NPY in AgRP-IRES-Cre::vGATlox/lox::NPY-KO mice. It is noteworthy that using an identical gene knockout approach, AgRP neuron stimulation of hunger was found to similarly depend on both NPY and GABA26. In our study, the presence of a corticosterone response after AgRP neuron stimulation in single knockout animals, although reduced in mice lacking vGAT, suggests redundancy between GABA and NPY, or that knockout of either transmitter during development can be functionally compensated for at least in part by the other. Given that NPY has prolonged effects on feeding36, it is also possible that NPY released by AgRP neurons primarily serves to sustain HPA activity levels during prolonged fasting37. Of note, NPY infusion into the PVH is sufficient to drive HPA activity and PVH-projecting hindbrain catecholaminergic neurons containing NPY are required to activate the HPA axis in response to hypoglycemia27,38. Therefore, NPY engagement of NPYR-expressing terminals of GABAergic afferents to PVHCrh neurons may play a more prominent role under these conditions. Nevertheless, given the importance of HPA axis activation in the fasted state, the potential for redundancy between GABA and NPY highlights that preserving release of glucocorticoids during fasting is crucial.
In this study, we discovered that disinhibition of PVHCrh neurons underlies HPA axis activation during fasting. However, it is plausible that relief of BNST-derived GABAergic tone onto PVHCrh neurons is a common means via which the HPA axis is activated by other stressors. In support of this, we found that terminals of BNST neurons in the PVH are also inhibited by a startling stimulus (Extended Data Fig. 2k, l). This indicates that the BNST may be a crucial circuit node through which a variety of stressful conditions drive glucocorticoid release. How this pathway might be recruited in response to acute stressors or more chronic states such as anxiety is an area for future investigation. In addition, our monosynaptic rabies mapping revealed that a number of brain areas contain putative PVHCrh neuron afferents, several of which are known to contain GABA neurons. It is conceivable that additional sources of GABA may also inhibit the HPA axis and that these may also be inhibited by AgRP neurons during fasting. The precise identity of these afferents to PVHCrh neurons and their role in HPA axis activation during fasting and other conditions will be an important area for further study
Dual actions of AgRP neurons in the PVH
AgRP neurons activate the HPA axis through their projections to the PVH where they cause excitation of PVHCrh neurons. This is particularly striking because AgRP neurons only release inhibitory neurotransmitters (GABA, NPY and AgRP) and previous reports have demonstrated that AgRP neurons regulate their downstream targets via direct inhibition14,19,39,40. Notably, the PVH is also the site where AgRP neurons cause hunger via monosynaptic inhibition of PVHMc4r and PVHPdyn neurons19,41. Thus, AgRP neurons can inhibit or excite different neurons in the same downstream area by direct inhibition or by modulating neurotransmission onto neurons with which they do not form synapses (Fig. 5p). Inhibition of PVHMc4r and PVHPdyn neurons to drive hunger is caused by direct synaptic contacts and engagement of GABA-A-Rs and NPYRs on the postsynaptic neurons. Consistent with PVHCrh neurons mediating fasting and AgRP neuron activation of the HPA axis, but not hunger19, they are not directly inhibited by AgRP neurons and are instead activated via the presynaptic disinhibition mechanism described above. In the absence of synaptic contact, levels of GABA are likely too low to engage GABA-A-Rs on PVHCrh neurons which have much lower affinity for GABA than GABA-B-Rs42,43. In addition, PVHCrh neurons express low levels of NPYRs (unpublished data and, ref. 44, Extended Data Fig. 2m). As a result, GABA-B-R-mediated inhibition of GABAergic afferents to PVHCrh neurons is the principal mechanism of AgRP neuron action on PVHCrh neurons. A previous study reported that 52% of AgRP neuron boutons in the PVH do not form post-synaptic contacts45– perhaps this is the source of GABA reaching GABA-B-Rs on BNST GABAergic inputs to PVHCrh neurons. Our data demonstrates that AgRP neurons have both direct and indirect modes of synaptic regulation within one downstream brain region. It is therefore possible that extra-synaptic release of transmitter from AgRP neurons at other sites in the brain may also contribute to differing effects on the activity of neurons in these areas and importantly, on the activity of their inputs. Together our findings in the PVH, and the differential control of hunger versus HPA axis activation, have wide-reaching implications for our understanding of how AgRP neurons coordinate specific activation and inhibition of functionally diverse neurons within the same downstream site.
Glucocorticoids activate AgRP neurons
In light of the importance of AgRP neurons in driving the HPA axis and corticosterone release, it is notable that AgRP neurons themselves are also activated by corticosterone and that this causes hunger and food intake46. Thus, AgRP neuron activity is driven by and also stimulates corticosterone release. We speculate that this could be a key aspect of their regulation and that sustained activity of AgRP neurons during fasting may in part be mediated by corticosterone and maintained by this positive feedback loop.
In summary, our work has revealed that activation of AgRP neurons causes HPA axis induction during fasting. In doing so, we have expanded our understanding of AgRP neuron function during fasting, and we have shed light on how AgRP neurons can both directly inhibit and indirectly activate key downstream target neurons. Moreover, we have also established an important mechanism of HPA axis activation, by providing concrete evidence that presynaptic inhibition of tonically active inhibitory afferent tone from the BNST is a critical physiologic driver of HPA axis activation (Fig. 5p).
Methods
Animals
All animal care and experimental procedures were approved by the Institutional Animal Care and Use Committees at Beth Israel Deaconess Medical Center and the University of Iowa. Prior to experiments mice were housed at 22-24°C, 20-30% humidity with a 12:12 light:dark cycle Mice had ad libitum access to chow (Envigo Teklad F6 8664) and water unless otherwise stated. Mice were singly housed at least one week prior to the start of experiments.
Male mice (8-20 weeks) were used for hormone measurement and fiber photometry experiments except for AgRP-IRES-Cre::vGATlox/lox::NPY-KO experiments where both male and female mice were used due to low likelihood of obtaining mice of the correct genotype. Both male and female mice were also used for anatomical and electrophysiological studies. C57BL6/J (JAX stock 000664), Agrp-IRES-Cre47 (JAX stock 012899), Crh-IRES-Cre48, Mc4r-t2a-Cre19 (JAX stock 030759), Pomc-IRES-Cre49, vGAT-IRES-Cre50(JAX stock 016962), Crh-IRES-FlpO (JAX stock 031559), R26-loxSTOPlox-L10-GFP48, Ai32(RCL-ChR2(H134R)/EYFP)51 (JAX stock 024109), Ai9(lox)-tdTomato51 (JAX stock 007909), RC:FLTG52 (JAX stock 026932), vGATlox/lox47 (JAX stock 012897), NPY-KO53 (JAX stock 004545) mice were maintained on a mixed background.
AAV construction
AAV2/9-hSyn-synaptophysin-GCaMP6f-WPRE was prepared and obtained from the University of Pennsylvania Vector Core. The rat synaptophysin-GCaMP6f was constructed from rat synaptophysin54 and GCaMP6f55 sequences by Gibson assembly (NEBuilder HiFi DNA Assembly, NEB) and enzymatically cloned into an AAV backbone with a human synapsin I promoter56. The pAAV-hSyn-synaptophysin-GCaMP6f- WPRE plasmid is available from Addgene (Plasmid #102996).
Stereotaxic surgeries
Mice were anesthetized with xylazine (10 mg per kg) and ketamine (100 mg per kg) diluted in 0.9% sterile isotonic saline and placed into a stereotaxic apparatus (KOPF model 940). For postoperative care, mice were injected subcutaneously with sustained-release meloxicam (4 mg per kg). After exposing the skull via small incision, a small hole was drilled for injection. A pulled-glass pipette with 20–40 μm tip diameter was inserted into the brain and virus was injected by an air pressure system controlled by a Grass Technologies stimulator (model S48) to deliver injections at 25 nl min−1. The pipette was withdrawn 5 min after injection.
For the arcuate, AAV was injected at 6 sites to cover the anterior-posterior extent of the arcuate (50 nl per site, bregma: AP: −1.5 mm and −1.7 mm, DV: −5.90 mm, ML: −0.25 mm, 0 mm, +0.25 mm). For photometry experiments, AAV was injected into the arcuate at 4 sites to prevent excessive spread (50 nl per site, bregma: AP: −1.5 mm and −1.7 mm, DV: −5.90 mm, ML: −0.25 mm and + 0.25 mm). For the PVH, 20 nl per site was injected at bregma, AP: −0.9 mm, DV: −4.8 mm, ML: ±0.16 mm. For the BNST, 20nl per site was injected at bregma, AP: +0.55 mm, DV: −4.8 mm, ML: ±0.65 mm. For the LH, 20nl per site was injected at bregma, AP: −1.5 mm, DV: −5.0 mm, ML: ±1.2 mm.
Animals were allowed to recover from stereotaxic surgery a minimum of 21 days prior to experiments. Following each experimental procedure, accuracy of AAV injections was confirmed via post hoc histological analysis of XFP reporters. All subjects determined to be surgical “misses” based on little or absent reporter expression were removed from analyses.
For chemogenetic experiments, AAV8-hSyn-DIO-mCherry (University of North Carolina (UNC) Vector Core; 2.1 × 1013 viral genomes ml−1), AAV8-hSyn-DIO-hM3Dq-mCherry (Boston Children’s Hospital (BCH) Viral Core) or AAV8-hSyn-DIO-hM4Di-mCherry (BCH Viral Core; 2 × 1013 viral genomes ml−1) were injected bilaterally into the arcuate of Agrp-IRES-Cre or Pomc-IRES-Cre mice; the PVH of Mc4r-2a-Cre mice; the BNST or LH of vGAT-IRES-Cre mice.
To label PVHCrh neuron somas, AAV1-Ef1a-Cre(ON)/Flp(OFF) 2.0-BFP (Addgene 137130-AAV1; 2.24 × 1013 viral genomes ml−1) was injected into the PVH of Crh-IRES-Cre mice.
For optogenetics experiments, AAV8-hSyn-DIO-mCherry (UNC Vector Core; 2.1 × 1013 viral genomes ml−1), AAV9-EF1a-DIO-ChR2(H134R)-mCherry (Addgene 20297-AAV9; 2.5 × 1013 viral genomes ml−1), AAV1-hSyn2-SIO-eOPN3-mScarlet-WPRE (Addgene 125713-AAV1; 1 × 1013 viral genomes ml−1) or AAV5-Syn-FLEX-rc[ChrimsonR-tdTomato] (Addgene 62723-AAV5; 2.1 × 1013 viral genomes ml−1) was injected bilaterally into the arcuate of Agrp-IRES-Cre mice, Agrp-IRES-Cre::NPY-KO mice, Agrp-IRES-Cre::vGATlox/lox or AgRP-IRES-Cre::vGATlox/lox::NPY-KO mice or the BNST of vGat-IRES-Cre mice. AAV9-EF1a-DIO-ChR2(H134R)-eYFP (Addgene 26973-AAV9; 2.2 × 1013 viral genomes ml−1) was injected into the BNST of vGAT-IRES-Cre::Crh-IRES-FlpO::FLTG mice.
For fiber photometry experiments, AAV1-hSyn-DIO-GCaMP6s (Addgene 100845- AAV1; 1.6 × 1013 viral genomes ml−1) was injected bilaterally into the PVH of Agrp-IRES-Cre::Crh-IRES-Cre mice. AAV2/9-hSyn-synaptophysin-GCaMP6f-WPRE (3.62 × 1013 viral genomes ml−1) was injected into the BNST of Agrp-IRES-Cre mice.
Optic fiber implants
For optogenetic experiments targeting the cell bodies of AgRP neurons, an optic fiber (200 μm diameter core; R-FOC_L200C-39NA; NA 0.39; RWD Life Science) was implanted at the midline over AgRP neurons (AP: −1.6 mm, DV: −5.85 mm, ML: 0 mm) of Agrp-IRES-Cre::LSL-ChR2-eYFP and Agrp-IRES-Cre::lox-L10-GFP mice or Agrp-IRES-Cre::NPY-KO, Agrp-IRES-Cre::vGATlox/lox or AgRP-IRES-Cre::vGATlox/lox::NPY-KO mice injected with AAV9-EF1a-DIO-ChR2(H134R)-mCherry. For AgRP neuron terminal stimulation experiments, optic fibers fiber (200 μm diameter core; R-FOC_L200C-39NA; NA 0.39; RWD Life Science) were implanted over one of the AgRP neuron terminal fields: PVH (AP: −0.9 mm, DV: −4.6 mm, ML: 0 mm), BNST (AP: +0.55 mm, DV: −4.35 mm, ML: −0.65 mm), LH (AP: −1.5 mm, DV: −4.5 mm, ML: −1.2 mm) or bilaterally over the PBN (AP: −5.25 mm, DV: −3.0 mm, ML: ±1.5 mm) of Agrp-IRES-Cre mice injected with AAV8-hSyn-DIO-mCherry or AAV9-EF1a-DIO-ChR2(H134R)-mCherry.
For AgRP neuron terminal inhibition experiments, optic fibers (200 μm diameter core; R-FOC_L200C-39NA; NA 0.39; RWD Life Science) were implanted over one of the AgRP neuron terminal fields: PVH (AP: −0.9 mm, DV: −4.6 mm, ML: 0 mm), BNST (AP: +0.55 mm, DV: Left −3.83 mm (angled at 20°) and Right −4.35 mm, ML: Left −2.19 mm (angled at 20° ) and Right +0.65 mm), LH (AP: −1.5 mm, DV: −4.5 mm, ML: ±1.2 mm) of Agrp-IRES-Cre mice injected with AAV8-hSyn-DIO-mCherry or AAV1-hSyn2-SIO-eOPN3-mScarlet-WPRE.
For BNST terminal inhibition experiments, a single optic fiber (200 μm diameter core; R-FOC_L200C-39NA; NA 0.39; RWD Life Science) was implanted over the PVH (AP: −0.9 mm, DV: −4.6 mm, ML: 0 mm) of vGAT-IRES-Cre mice injected with AAV1-hSyn2-SIO-eOPN3-mScarlet-WPRE or AAV8-hSyn-DIO-mCherry.
For fiber photometry recordings, an optic fiber (400 um diameter core; MFC_400/430-0.66_7mm_MF1.25_FLT; NA 0.66; Doric Lenses) was placed over the PVH (AP: −0.9, DV: −4.7, ML: −0.15).
Fibers were fixed to the skull using dental acrylic. Following experiments and histology of the brain tissue, the location of the fiber tips were identified.
Monosynaptic rabies mapping
For monosynaptic rabies mapping, AAV8-Ef1a-FLEX-TVA-mCherry (UNC Vector Core; 1.13 x 1012 viral genomes ml−1) and AAV8-CAG-FLEX-rabiesG (Stanford Vector Core; 3.4 x 1012 viral genomes ml−1) (mixed 1:1, 20 nl) were injected into the PVH of Crh-IRES-Cre using the coordinates above. After three weeks, the mice underwent a second surgery where 20 nl EnvA-ΔG-rabies-GFP (Salk Viral Vector Core; 1.51 x 108 viral genomes ml−1) was injected into the PVH. 6 days following rabies virus injection the mice were processed for histological analysis.
Collateral mapping
For TVA-only rabies mapping, AAV8-Ef1a-FLEX-TVA-mCherry was injected into the arcuate of Agrp-IRES-Cre mice using the coordinates above. After three weeks, EnvA-ΔG-rabies-GFP (10-100 nl per site) was injected into one of the following AgRP neuron terminal fields: PVH (AP: −0.9 mm, DV: −4.8 mm, ML: ±0.16 mm), BNST (AP: +0.55 mm, DV: −4.8 mm, ML: ±0.65 mm), LH (AP: −1.5 mm, DV: −5.0 mm, ML: ±1.2 mm), PBN (AP: −5.3 mm, DV: −3.5 mm, ML: ±1.7 mm). Animals were perfused 6 days after injection of the rabies virus.
For retro-AAV-based collateral mapping, retroAAV-EF1a-FlpO (Addgene 55637-AAVrg; 1.02 x 1013 viral genomes ml−1) (10-100nl per site) was injected into AgRP neuron terminal fields (as for TVA-only rabies mapping) of Agrp-IRES-Cre::FLTG mice. Animals were perfused 4 weeks post injection. Presence of collaterals was performed by immunofluorescent detection of GFP and analysis of all AgRP neuron projection fields.
Infusion cannula implants and in vivo pharmacology
Bilateral intrahypothalamic guide cannula (C235G, 26G, 3.25 mm length, P1 Technologies) were implanted at the midline above the PVH of C57Bl6/J mice (AP: −0.9, ML: ±0.25, DV: −3.25). Cannula were fixed to the skull using dental acrylic. Bilateral dummy cannula (C235DC, 26G, 3.25 mm + 0.5 mm projection, P1 Technologies) were placed into the guide cannula until experiments.
Microinjection of antagonists into the PVH was performed in freely-moving mice. Mice were habituated to tethering for two days prior to experiments. Bilateral internal cannula (C2351, 33G, 3.25 mm + 1.5 mm projection, P1 Technologies) were placed into the guide cannula and connected to infusion tubing (C232CT, P1 Technologies) via a connector (C230C/SPC, P1 Technologies). Infusion tubing was connected to a Hamilton syringe (22G, 1 μl) controlled by a syringe pump (NE-4000 New Era). Prior to experiments, the mice were placed into a fresh home cage and fasted for 24 hours, from 1 hour prior to the onset of the dark cycle. GABA-B-R antagonist (2-hydroxysaclofen, 3.1 mM per side, Tocris), NPY2R antagonist (BIIE0246, 0.5 mM per side, Tocris), GABA-B-R + NPY2R antagonists or vehicle (10% DMSO, Sigma) were infused over 2 hours at a rate of 10 nl per minute per side (total volume 1.2 μl). Immediately after infusions the mice were rapidly decapitated for trunk blood collection and brains were collected for histological assessment of guide cannula location.
Optogenetic experiments
All optogenetic experiments were performed with singly housed animals in the presence of food unless otherwise stated.
For optogenetic stimulation of AgRP neurons and terminals with ChR2, mice were tethered to optic fiber patch cords in the home cage and allowed to acclimate for 2 hours prior to experiments. The mice received photostimulation (473 nm; 10 ms pulses of 20 Hz at ~10mW; 1 s ON, 3 s OFF) for 10 minutes, after which they were rapidly decapitated and trunk blood was collected. Experiments were performed 4 hours after the onset of the light phase.
For optogenetic inhibition of AgRP neuron terminals with eOPN3, mice were placed into a fresh home cage and fasted for 24 hours from 1 hour prior to the onset of the dark cycle. The next day, 3 hours prior to the dark phase, the mice were tethered to optic fiber patch cords and received photoinhibition (473 nm, 10 ms pulses at 10Hz at ~5mW, 2 s ON, 2 s OFF ) for 2 hours, after which they were rapidly decapitated and trunk blood was collected.
To optogenetically inhibit BNSTvGAT neuron terminals in the PVH with eOPN3, mice were tethered to optic fiber patch cables 1 hour after the onset of the light cycle. After 1 hour the stimulation commenced (473 nm, 10 ms pulses at 10Hz ~5mW, 2 s ON, 2 s OFF) for 1 hour, after which the mice were rapidly decapitated and trunk blood was collected.
Chemogenetic experiments
For measurements in the fed state, Agrp-IRES-Cre mice expressing hM3Dq or mCherry in the arcuate, vGAT-IRES-Cre mice expressing hM4Di or mCherry in the BNST or LH were injected I.P. with CNO (1 mg kg−1; 0.5% body weight volume) two hours after the onset of the light cycle. One hour later the mice were rapidly decapitated and trunk blood was collected. Experiments were performed in the presence of food.
For PVHMc4r neuron inhibition, Mc4r-t2a-Cre mice expressing hM4Di or mCherry in the PVH were first tested for increased food intake by injecting vehicle or CNO (1 mg kg−1; 0.5% body weight volume) I.P. two hours after the onset of the light cycle and measuring food intake over the following three hours. One week later, the same mice were injected with CNO two hours after the onset of the light cycle and were rapidly decapitated for trunk blood collection one hour later. Experiments were performed in the presence of food.
For measurements in the fasted state, Agrp-IRES-Cre mice expressing hM4Di or mCherry in the arcuate and Pomc-IRES-Cre mice expressing hM3Dq and mCherry in the arcuate were placed into a fresh home cage and fasted for 24 hours, from one hour prior to the onset of the dark cycle. One hour prior to sacrifice, mice were injected I.P. with CNO. The mice were then rapidly decapitated and trunk blood was collected.
Leptin treatment
C57BL6 mice were placed into a fresh home cage and fasted for 24 hours, from 1 hour prior to the onset of the dark cycle. 1.5 hours prior to sacrifice, mice were injected I.P. with vehicle or recombinant leptin (5 mg/kg). The mice were rapidly decapitated and trunk blood was collected.
Hormone Measurements
Collected trunk blood was centrifuged for plasma collection. Plasma was run in duplicate in a 96 well plate enzyme-linked immunosorbent assay (ELISA) kit for corticosterone (Enzo Life Sciences) according to the manufacturer’s protocol. ACTH was measured using radioimmunoassay by the Brigham Research Assay Core (Brigham and Woman’s Hospital).
Fiber photometry
Fiber photometry was performed using a Micropython microcontroller-based pyPhotometry57 acquisition system. 465 nm and 405 nm LED (Doric Lenses) excitation sources were passed through a fluorescence mini cube (Excitation: 460-490 nm and 400-410 nm, Emission: 500-550nm, Doric Lenses). The excitation light was transmitted onto the sample via an optic fiber cable (1 m long; 400 μm diameter NA 0.48; Doric Lenses) coupled to the implanted optic fiber via a ceramic mating sleeve (Thor Labs). Light intensity at the end of the patch cord (30-60 μW) was kept constant across sessions for each mouse. Time-division multiplexed illumination was performed at 20Hz and the signal was collected by a photodetector (Doric lenses) and digitized by the Micropython acquisition board.
Recordings were performed in Agrp-IRES-Cre::Crh-IRES-Cre mice that express AAV1-hSyn-DIO-GCaMP6s in the PVH and AAV8-hSyn-DIO-hM3Dq-mCherry, AAV8-hSyn-DIO-hM4Di-mCherry or AAV8-hSyn-DIO-mCherry in the arcuate. Experiments were performed within-subject with each animal receiving 2 x vehicle and 2 x CNO (1 mg/kg) trial in counterbalanced order with at least 3 days between trials for experiments in which AgRP neurons were activated. For experiments where AgRP neurons were inhibited, fasted mice received 1 x vehicle and 1 x CNO injection with 5 days recovery between trials. Mice were habituated to tethering and I.P. injection for two days prior to the first recording.
Recordings from BNST terminals in the PVH were performed concurrent with AgRP neuron stimulation through the same optic fiber. 465 nm, 405 nm LED (Doric Lenses) and 630 nm (Plexon) excitation sources were passed through a fluorescence mini cube (Photometry Excitation: 460-490 nm and 400-410 nm, Optogenetic Excitation: 580-680 nm, Photometry Emission: 500-540nm, Doric Lenses). For fiber photometry recordings, time-division multiplexed illumination was performed at 20 Hz. Optogenetic stimulation was interleaved between the 465 and 405 nm pulses at 20 Hz to prevent cross-talk between the stimulation and fiber photometry recording using an Arduino board running custom code synchronized to the pyPhotometry system. Signal was collected by a photodetector (Newport 2151) and digitized by the Micropython acquisition board.
Fiber photometry analysis
Fiber photometry data was analyzed using a custom Python (Python 3.6) script. All data were median filtered and low pass filtered (10Hz cutoff). Photobleaching was corrected by fitting an exponential curve to the data and subtracting it from the signal. Motion correction was performed by finding a linear best fit to the 405 nm signal and subtracting this from the 465 nm signal. ΔF/F was calculated as (465 nm – 405 nm fitted signal) / F0, where F0 is the low-pass filtered 465 nm signal (0.001 Hz cutoff) of the whole recording session. For experiments where CNO/Saline was administered IP, trials were renormalized by subtracting the mean of the 5 minute baseline prior to the injection from the trace following IP injection. All trials of a treatment type were averaged to calculate the mean response (0-5 minutes pre-injection and 0-30 minutes after IP injection). Signals from recordings performed with optogenetic stimulation experiments were renormalized by subtracting the mean either a 50 second or 5 minute baseline prior to onset of the 630 nm stimulus. Traces were finally smoothed using a 10 second running average.
Electrophysiology
To prepare ex vivo murine brain slices, animals were deeply anesthetized with isoflurane before decapitation and removal of the entire brain. Brains were immediately submerged in ice-cold, carbogen-saturated (95% O2, 5% CO2) choline-based cutting solution consisting of (in mM): 92 choline chloride, 10 HEPES, 2.5 KCl, 1.25 NaH2PO4, 30 NaHCO3, 25 glucose, 10 MgSO4, 0.5 CaCl2, 2 thiourea, 5 sodium ascorbate, 3 sodium pyruvate, oxygenated with 95% O2/5% CO2, measured osmolarity 310 – 320 mOsm/L, pH= 7.4. Then, 275-300 μm-thick coronal sections were cut with a vibratome (Campden 7000smz-2) and incubated in oxygenated cutting solution at 34°C for 10 min. Next, slices were transferred to oxygenated aCSF (126 mM NaCl, 21.4 mM NaHCO3, 2.5 mM KCl, 1.2 mM NaH2PO4, 1.2 mM MgCl2, 2.4 mM CaCl2, 10 mM glucose) at 34°C for an additional 15 min. Slices were then kept at room temperature (20–24°C) for ≥45 min until use. A single slice was placed in the recording chamber where it was continuously superfused at a rate of 3–4 mL per min with oxygenated aCSF. Neurons were visualized with an upright microscope (SliceScope Pro 1000, Scientifica) equipped with infrared-differential interference contrast and fluorescence optics.
Electrically-evoked recordings
GABAergic transmission was recorded in whole-cell voltage-clamp mode, with membrane potential clamped at −70 mV using borosilicate glass microelectrodes (3–5 MΩ) filled with internal solution consisting of (in mM): 140 CsCl, 1 BAPTA, 10 HEPES, 5 MgCl2, 5 Mg-ATP, 0.3 Na2GTP, and 10 lidocaine N-ethyl bromide (QX-314), pH 7.35 and 290 mOsm. Glutamate receptor antagonists (1 mM kynurenate or 10 μM CNQX and 50 μM DAP-5) were used to isolate inhibitory postsynaptic currents (IPSCs). Electrically-evoked IPSCs were elicited by applying a pair (100 ms interstimulus interval;ISI) of 50 μs current pulses at 0.1 Hz through a bipolar tungsten electrode (resistance = 1 MΩ; WPI, Sarasota, FL) positioned 100-150 μm lateral to the patched neuron in the PVH. The intensity of the stimulation was adjusted so that the average IPSC amplitude was ~75-80% of maximal amplitude for each recording and ranged from 50-600 μA. For pharmacological recordings (Fig 3), GDP-β-S was included in the pipette to block potential postsynaptic GABAB responses. The paired pulse ratio (PPR) of evoked IPSCs was calculated by dividing the mean peak amplitude of the second evoked response (A2) by the mean peak amplitude of the first response (A1) (PPR= mean A2/ mean A1) during the 2 min epoch prior to drug application and during the last 2 min of drug exposure. Drugs for pharmacology recordings: GABAB receptor agonist (baclofen, 30 μM; Tocris) and antagonists (saclofen, 200μM or CGP 52432,10 μM; Tocris); neuropeptide Y (NPY, 300 nM; Anaspec), and NPY receptor antagonists (NPY1 receptor: BIBO3304, 100 nM; NPY2 receptor: BIIE0246, 100 nM; NPY5 receptor: CGP71683, 100 nM; Tocris) were prepared and used according to manufacturer’s specifications.
ChR2-assisted circuit mapping (CRACM)
In vGAT-IRES-Cre::Crh-IRES-FlpO::FLTG mice, CRH neurons in the PVH were genetically labeled with a Flp-dependent tdTomato tag (i.e. CRH--IRES-FlpO::tdTomato) and AAV9-EF1a-DIO-ChR2(H134R)-eYFP was expressed in the BNST. Open-tip resistances for patch pipettes were 3-5 MΩ and were backfilled with the same internal described in the previous section. Light-evoked IPSCs were isolated using glutamate receptor antagonists (1 mM kynurenate or 10 μM CNQX and 50 μM AP-5). To photostimulate ChR2-positive fibers, an LED light source was used (470 nm, Cool LED pE-100). The blue light was focused onto the back aperture of the microscope objective (40X) producing wide-field exposure around the recorded neuron of 10-15 mW per mm2 as measured using an optical power meter (PM100D, Thorlabs). The light output was controlled by a programmable pulse stimulator (Master 8, A.M.P.I.) and pClamp 10.5 software (Axon Instruments). The light-evoked IPSC protocol consisted of four blue light pulses (470 nm wavelength, 2 ms duration) administered 1 s apart during the first 4 s of a 10-s sweep, repeated for a total of 30 sweeps. Evoked IPSCs with short latency (≤6 ms) upon light stimulation were considered as light-driven.
Analysis
All recordings were made using a Multiclamp 700B amplifier, and data were filtered at 2 kHz and digitized at 20 Hz. Access resistance (<30 MΩ) was continuously monitored by a voltage step and recordings were accepted for analysis if changes were <15%. All recordings were analyzed offline using Clampfit 10.5. eIPSC amplitude upon application of drugs was compared as follows: For onedrug experiments, baseline (3 minutes preceding drug application) and Drug (the last 3 minutes of the recording). For two-drug experiments (sequential NPY and Baclofen), baseline (2 minutes preceding drug application, first drug (the last 2 minutes of the recording prior to drug 2), and second drug (last 2 mins of the recording).
Single-cell RNA sequencing of analysis of PVH neurons
Previously published data from PVH neurons was obtained from the NCBI Gene Expression Omnibus database (GSE148568)44. Data were processed and analyzed in R using Seurat version 458. The SCTransform function was used to scale, normalize, and identify variable genes. Principal component analysis on the 3,000 most variable genes was used for dimensionality reduction and cell clustering. Initial cell clustering identified two small non-neuronal clusters and one small cluster with low gene detection. These clusters were subsequently removed and the remaining 766 PVH neurons were reclustered as above. Differential expression analysis across cell clusters was done with the Wilcoxon Rank Sum test to identify marker genes for putative PVH cell types and clusters were named based on previously reported marker genes44.
Histology
Mice were terminally anesthetized with 7% choral hydrate (500 mg/kg; Sigma Aldrich) diluted in saline and transcardially perfused with 0.1 M phosphate-buffered saline (PBS) followed by 10% neutral-buffered formalin solution (NBF; Thermo Fisher Scientific). Extracted brains were post-fixed overnight at 4°C in NBF, cryoprotected in 20% sucrose, sectioned coronally at 30 μm on a freezing microtome (Leica Biosystems), and stored in cryoprotectant solution at −20°C until used for immunohistochemistry.
Immunohistochemistry
Brain sections were washed 3X in PBS prior to blocking (3% normal donkey serum and 0.4% Triton X-100 in PBS) for one hour at room temperature. Primary antibody was diluted in blocking solution and incubated overnight at room temperature. The following antibodies were used: Chicken anti-GFP (Invitrogen; 1:3000, A10262) and Goat anti-AgRP (Neuromics; 1:3000, GT15023). The following day the sections were washed 5X in PBS, then incubated for 2 hours at room temperature in donkey anti-chicken Alexa Fluor 488-conjugated secondary antibody (Jackson ImmunoResearch; 1:1000, 703-545-155) or donkey anti-goat Alexa Fluor 647 fluorescent secondary antibody (Invitrogen; 1:1000, A21447) prepared in blocking solution. Finally, sections were washed 3X in PBS, mounted on gelatin-coated slides, and coverslipped with VECTASHIELD® Antifade Mounting Medium, with DAPI (Vector Laboratories). Fluorescent images were taken using an Olympus VS120 slide-scanning microscope or a confocal microscope (Zeiss LSM 880). Fluorescent images were adjusted minimally for brightness and contrast using Olympus OlyVIA (3.4.1) and Image J (1.53c)
Data Analysis
Statistical analyses were performed using GraphPad Prism 8 software and are described in the figure legends. No statistical method was used to predetermine sample size, nor were randomization and blinding methods used. Statistical significance was defined as p < 0.05. All data presented met the assumptions of the statistical test employed. Experimental animals were excluded if histological validation revealed poor or absent reporter expression. N values reflect the final number of validated animals per group.
Extended Data
Acknowledgements
We thank Mark Andermann, Joe Majzoub and the Lowell laboratory for helpful discussions; Jia Yu, Chen Wu and Yanfang Li for technical assistance; Steve Liberles for providing the NPY-KO mice; and the Brigham Assay Core for running the ACTH radioimmunoassay. The confocal imaging was performed at BIDMC’s Confocal Imaging Core. This work was supported by the NIH (P30DK046200, R01DK122976, R01DK075632, R01DK089044, R01DK111401, R01DK096010 to B.B.L and R00HL144923 to J.M.R). A.M.D was supported the Charles A. King Trust Postdoctoral Research Fellowship Program. H.K. was supported by a BBRF Young Investigator Grant.
Footnotes
Competing interests
The authors declare no competing interests.
Data Availability
Fiber photometry data reported in this study is available from:https://research.bidmc.harvard.edu/datashare/DataShareInfo.ASP?Submit=Display&ID=9. Source data are provided with this paper.
Code Availability
The custom analysis code used in this study is available on Github.(https://github.com/AMDouglass/Douglass_Resch_Madara_etal)
References
- 1.Ahima RS et al. Role of leptin in the neuroendocrine response to fasting. Nature 382, 250–252 (1996). [DOI] [PubMed] [Google Scholar]
- 2.Dallman MF et al. Starvation: Early Signals, Sensors, and Sequelae. Endocrinology 140, 4015–4023 (1999). [DOI] [PubMed] [Google Scholar]
- 3.Perry RJ et al. Leptin Mediates a Glucose-Fatty Acid Cycle to Maintain Glucose Homeostasis in Starvation. Cell 172, 234–236.e17 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Muglia L, Jacobson L, Dikkest P & Majzoub JA Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373, 427–432 (1995). [DOI] [PubMed] [Google Scholar]
- 5.Steinhauser ML et al. The circulating metabolome of human starvation. JCI Insight 3, e121434 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Long CNH, Katzin B & Fry EG The adrenal cortex and carbohydrate metabolism. Endocrinology 26, 309–344 (1940). [Google Scholar]
- 7.Chihaoui M. et al. The risk for hypoglycemia during Ramadan fasting in patients with adrenal insufficiency. Nutrition 45, 99–103 (2018). [DOI] [PubMed] [Google Scholar]
- 8.Exton J. Regulation of gluconeogenesis by glucocorticoids. Monogr Endocrinol 12, 535–46 (1979). [DOI] [PubMed] [Google Scholar]
- 9.Kuo T, McQueen A, Chen TC & Wang JC Regulation of Glucose Homeostasis by Glucocorticoids. Adv. Exp. Med. Biol 872, 99 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Goldberg AL, Tischler M, DeMartino G, G. G. Hormonal regulation of protein degradation and synthesis in skeletal muscle. Fed Proc 39, 31–6 (1980). [PubMed] [Google Scholar]
- 11.Djurhuus CB et al. Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. Am. J. Physiol. - Endocrinol. Metab 283, 46–1 (2002). [DOI] [PubMed] [Google Scholar]
- 12.Aponte Y, Atasoy D & Sternson SM AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat. Neurosci 14, 351–355 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Krashes MJ et al. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J. Clin. Invest 121, 1424–8 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Livneh Y. et al. Homeostatic circuits selectively gate food cue responses in insular cortex. Nature 546, 611–616 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Fernandes ACA et al. Arcuate AgRP, but not POMC neurons, modulate paraventricular CRF synthesis and release in response to fasting. Cell Biosci. 12, 1–14 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Spencer RL & Deak T A users guide to HPA axis research. Physiology and Behavior 178, 43–65 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Betley JN, Cao ZFH, Ritola KD & Sternson SM Parallel, redundant circuit organization for homeostatic control of feeding behavior. Cell 155, 1337–50 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Betley JN et al. Neurons for hunger and thirst transmit a negative-valence teaching signal. Nature 521, 180–185 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Garfield AS et al. A neural basis for melanocortin-4 receptor–regulated appetite. Nat. Neurosci 18, 863–871 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Mahn M. et al. Efficient optogenetic silencing of neurotransmitter release with a mosquito rhodopsin. Neuron 109, 1621–1635.e8 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Ziegler DR, Cullinan WE & Herman JP Distribution of vesicular glutamate transporter mRNA in rat hypothalamus. J. Comp. Neurol 448, 217–229 (2002). [DOI] [PubMed] [Google Scholar]
- 22.Cowley MA et al. Integration of npy, agrp, and melanocortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat. Neuron 24, 155–163 (1999). [DOI] [PubMed] [Google Scholar]
- 23.Pronchuk N, Beck-Sickinger AG & Colmers WF Multiple NPY receptors inhibit GABAA synaptic responses of rat medial parvocellular effector neurons in the hypothalamic paraventricular nucleus. Endocrinology 143, 535–543 (2002). [DOI] [PubMed] [Google Scholar]
- 24.Mackay JP et al. NPY2 receptors reduce tonic action potential-independent gabab currents in the basolateral amygdala. J. Neurosci 39, 4909–4930 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Colmers PLW & Bains JS Balancing tonic and phasic inhibition in hypothalamic corticotropin-releasing hormone neurons. J. Physiol 596, 1919–1929 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Krashes MJ, Shah BP, Koda S & Lowell BB Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP. Cell Metab. 18, 588–95 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wahlestedt C. et al. Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res. 417, 33–38 (1987). [DOI] [PubMed] [Google Scholar]
- 28.Johnson CS, Bains JS & Watts AG Neurotransmitter diversity in pre-synaptic terminals located in the parvicellular neuroendocrine paraventricular nucleus of the rat and mouse hypothalamus. J. Comp. Neurol 526, 1287–1306 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Cole RL & Sawchenko PE Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus. J. Neurosci 22, 959–969 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Roland BL & Sawchenko PE Local origins of some GABAergic projections to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J. Comp. Neurol 332, 123–143 (1993). [DOI] [PubMed] [Google Scholar]
- 31.Cullinan WE, Ziegler DR & Herman JP Functional role of local GABAergic influences on the HPA axis. Brain Structure and Function 213, 63–72 (2008). [DOI] [PubMed] [Google Scholar]
- 32.Johnson SB et al. A Basal Forebrain Site Coordinates the Modulation of Endocrine and Behavioral Stress Responses via Divergent Neural Pathways. J. Neurosci 36, 8687–8699 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Radley JJ, Gosselink KL & Sawchenko PE A Discrete GABAergic Relay Mediates Medial Prefrontal Cortical Inhibition of the Neuroendocrine Stress Response. J. Neurosci 29, 7330–7340 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Michel MC et al. XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors. Pharmacol. Rev 50, (1998). [PubMed] [Google Scholar]
- 35.Woodward CJH, Hervey GR, Oakey RE & Whitaker EM The effects of fasting on plasma corticosterone kinetics in rats. Br. J. Nutr 66, 117–127 (1991). [DOI] [PubMed] [Google Scholar]
- 36.Chen Y. et al. Sustained NPY signaling enables AgRP neurons to drive feeding. Elife 8, (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Wahlestedt C, Hakanson R, Vaz CA & Zukowska-Grojec Z Norepinephrine and neuropeptide Y: vasoconstrictor cooperation in vivo and in vitro. Am. J. Physiol. Integr. Comp. Physiol 258, (1990). [DOI] [PubMed] [Google Scholar]
- 38.Khan AM et al. MAP Kinases Couple Hindbrain-Derived Catecholamine Signals to Hypothalamic Adrenocortical Control Mechanisms during Glycemia-Related Challenges. J. Neurosci 31, 18479–18491 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Atasoy D, Betley JN, Su HH & Sternson SM Deconstruction of a neural circuit for hunger. Nature 488, 172–177 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Padilla SL et al. Agouti-related peptide neural circuits mediate adaptive behaviors in the starved state. Nat. Neurosci 19, 734–741 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Li MM et al. The Paraventricular Hypothalamus Regulates Satiety and Prevents Obesity via Two Genetically Distinct Circuits. Neuron 102, 653–667.e6 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Baur R & Sigel E On high- and low-affinity agonist sites in GABAA receptors. J. Neurochem 87, 325–332 (2003). [DOI] [PubMed] [Google Scholar]
- 43.Hill DR & Bowery NG 3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABAB sites in rat brain. Nat. 1981 2905802 290, 149–152 (1981). [DOI] [PubMed] [Google Scholar]
- 44.Xu S. et al. Behavioral state coding by molecularly defined paraventricular hypothalamic cell type ensembles. Science (80-. ). 370, (2020). [DOI] [PubMed] [Google Scholar]
- 45.Atasoy D. et al. A genetically specified connectomics approach applied to long-range feeding regulatory circuits. Nat. Neurosci. 2014 1712 17, 1830–1839 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Perry RJ et al. Leptin’s hunger-suppressing effects are mediated by the hypothalamic–pituitary–adrenocortical axis in rodents. Proc. Natl. Acad. Sci. U. S. A 116, 13670–13679 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Tong Q, Ye CP, Jones JE, Elmquist JK & Lowell BB Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat. Neurosci. 2008 119 11, 998–1000 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Krashes MJ et al. An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger. Nature 507, 238–242 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Fenselau H. et al. A rapidly acting glutamatergic ARC→PVH satiety circuit postsynaptically regulated by α-MSH. Nat. Neurosci. 2016 201 20, 42–51 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Vong L. et al. Leptin Action on GABAergic Neurons Prevents Obesity and Reduces Inhibitory Tone to POMC Neurons. Neuron 71, 142–154 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Madisen L. et al. A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing. Nat. Neurosci. 2012 155 15, 793–802 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Plummer NW et al. Expanding the power of recombinase-based labeling to uncover cellular diversity. Dev. 142, 4385–4393 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Erickson C, Clegg KE & Palmiter RD Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nat. 1996 3816581 381, 415–418 (1996). [DOI] [PubMed] [Google Scholar]
- 54.Harms KJ, Tovar KR & Craig AM Synapse-Specific Regulation of AMPA Receptor Subunit Composition by Activity. J. Neurosci 25, 6379–6388 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Chen TW et al. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nat. 2013 4997458 499, 295–300 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Atasoy D, Aponte Y, Su HH & Sternson SM A FLEX Switch Targets Channelrhodopsin-2 to Multiple Cell Types for Imaging and Long-Range Circuit Mapping. J. Neurosci 28, 7025–7030 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Akam T & Walton ME pyPhotometry: Open source Python based hardware and software for fiber photometry data acquisition. Sci. Rep 9, 1–11 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Hao Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e29 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Fiber photometry data reported in this study is available from:https://research.bidmc.harvard.edu/datashare/DataShareInfo.ASP?Submit=Display&ID=9. Source data are provided with this paper.
The custom analysis code used in this study is available on Github.(https://github.com/AMDouglass/Douglass_Resch_Madara_etal)